Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Abdul Latif, Al Khal"'
Autor:
Mazen A. Sid Ahmed, Emad Bashir Ibrahim, Jemal M. Hamid, Joanne Daghfal, Mohammed A. Alyazidi, Aimen H. Abdelwahab, Muna A. Al-Maslamani, Abdul Latif Al Khal, Hamad Abdel Hadi
Publikováno v:
Oman Medical Journal, Vol 37, Iss 5, Pp e422-e422 (2022)
Objectives: Extended-spectrum β-lactamases (ESBLs) mechanism of resistance in Enterobacterales leads to poor clinical outcomes. Ceftazidime/avibactam and ceftolozane/tazobactam are two broad-spectrum antimicrobial combinations that are effective aga
Externí odkaz:
https://doaj.org/article/e6af5a2e723f4320852e56814f6bb6e3
Autor:
Mazen A. Sid Ahmed, Jemal M. Hamid, Ahmed A. Husain, Hamad Abdel Hadi, Sini Skariah, Ali A. Sultan, Emad Bashir Ibrahim, Abdul Latif Al Khal, Bo Soderquist, Jana Jass, Ali S. Omrani
Publikováno v:
Annals of Medicine, Vol 53, Iss 1, Pp 2345-2353 (2021)
AbstractBackground Bloodstream infections (BSIs) caused by multidrug-resistant (MDR)-Pseudomonas aeruginosa are associated with poor clinical outcomes, at least partly due to delayed appropriate antimicrobial therapy. The characteristics of MDR-P. ae
Externí odkaz:
https://doaj.org/article/4cc27fc920a74078bc4262f01102d0be
Autor:
Mazen A. Sid Ahmed, Hamad Abdel Hadi, Sulieman Abu Jarir, Faisal Ahmad Khan, Mohammed A. Arbab, Jemal M. Hamid, Mohammed A. Alyazidi, Muna A. Al-Maslamani, Sini Skariah, Ali A. Sultan, Abdul Latif Al Khal, Bo Söderquist, Emad Bashir Ibrahim, Jana Jass, Hisham Ziglam
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objectives: Antimicrobial resistance (AMR) is a global priority with significant clinical and economic consequences. Multidrug-resistant (MDR) Pseudomonas aeruginosa is one of the major pathogens associated with significant morbidity and mo
Externí odkaz:
https://doaj.org/article/505ddf6640fc47f8be5f08ac3e456873
Autor:
Farhan S. Cyprian, Muhammad Suleman, Ibrahim Abdelhafez, Asmma Doudin, Ibn Mohammed Masud Danjuma, Fayaz Ahmad Mir, Aijaz Parray, Zohaib Yousaf, Mohammed Yaseen Ahmed Siddiqui, Alaaedin Abdelmajid, Mohammad Mulhim, Shaikha Al-Shokri, Mohammad Abukhattab, Ranad Shaheen, Eyad Elkord, Abdul Latif Al-khal, Abdel-Naser Elzouki, Guillermina Girardi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Coronavirus disease-2019 (COVID-19) was declared as a pandemic by WHO in March 2020. SARS-CoV-2 causes a wide range of illness from asymptomatic to life-threatening. There is an essential need to identify biomarkers to predict disease severity and mo
Externí odkaz:
https://doaj.org/article/6039d3a5a8aa45719fab5f141299d3e8
Publikováno v:
International Journal of Travel Medicine and Global Health, Vol 6, Iss 4, Pp 161-167 (2018)
Introduction: The number of international travelers is increasing, yet currently, there is no data on risk assessment and travelers’ characteristics from Qatar. To identify and minimize the risks associated with travel, a detailed knowledge of trav
Externí odkaz:
https://doaj.org/article/12ec316374c54dacaec12eda6d132170
Autor:
Mazen A. Sid Ahmed, Faisal Ahmad Khan, Hamad Abdel Hadi, Sini Skariah, Ali A. Sultan, Abdul Salam, Abdul Latif Al Khal, Bo Söderquist, Emad Bashir Ibrahim, Ali S. Omrani, Jana Jass
Publikováno v:
Antibiotics, Vol 11, Iss 2, p 130 (2022)
Ceftazidime–avibactam and ceftolozane–tazobactam are approved for the treatment of complicated Gram-negative bacterial infections including multidrug-resistant (MDR) Pseudomonas aeruginosa. Resistance to both agents has been reported, but the und
Externí odkaz:
https://doaj.org/article/c8a9838fdf894f6a92b769c413e21edf
Autor:
Aijaz Parray, Fayaz Ahmad Mir, Asmma Doudin, Ahmad Iskandarani, Ibn Mohammed Masud Danjuma, Rahim Ayadathil Thazhhe Kuni, Alaaedin Abdelmajid, Ibrahim Abdelhafez, Rida Arif, Mohammad Mulhim, Mohammad Abukhattab, Shoukat Rashhid Dar, Ala-Eddin Al Moustafa, Eyad Elkord, Abdul Latif Al Khal, Abdel-Naser Elzouki, Farhan Cyprian
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1056 (2021)
There is a lack of predictive markers for early and rapid identification of disease progression in COVID-19 patients. Our study aims at identifying microRNAs (miRNAs)/small nucleolar RNAs (snoRNAs) as potential biomarkers of COVID-19 severity. Using
Externí odkaz:
https://doaj.org/article/a1774295d45b4c9890780d7d124a9320
Autor:
Amal Khidir, Humna Asad, Huda Abdelrahim, Maha Elnashar, Amal Killawi, Maya Hammoud, Abdul Latif Al-Khal, Pascale Haddad, Michael D. Fetters
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-14 (2016)
Abstract Background Health care researchers working in the Arabian Gulf need information on how to optimize recruitment and retention of study participants in extremely culturally diverse settings. Implemented in Doha, Qatar in 2012 with 4 language g
Externí odkaz:
https://doaj.org/article/11d43d0dd36e4535933266bed93460d6
Autor:
Mazen A Sid Ahmed, Thoraya M Saleh, Mohamed Albirair, Khalid M Dousa, Lolita C Arisgado, Muna A Al Maslamani, Abdul Latif Al Khal, Emad B Ibrahim, Hamad Abdel Hadi
Publikováno v:
Open Forum Infectious Diseases. 9
Background Monitoring Antimicrobial Resistance Trends (SMART) is a global study for the surveillance of antimicrobial resistance (AMR) in Gram-negative bacteria (GNB) from different regions around the World including Gulf countries. To evaluate preva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ddbea29f00be10e2645bdce8fc1203b
https://doi.org/10.1093/ofid/ofac492.1355
https://doi.org/10.1093/ofid/ofac492.1355
Autor:
Heba N Altarawneh, Hiam Chemaitelly, Houssein H Ayoub, Patrick Tang, Mohammad R Hasan, Hadi M Yassine, Hebah A Al-Khatib, Maria K Smatti, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F Abdul-Rahim, Gheyath K Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A Butt, Hamad Eid Al-Romaihi, Mohamed H Al-Thani, Abdul Latif Al Khal, Roberto Bertollini, Laith J Abu-Raddad
Publikováno v:
Open Forum Infectious Diseases. 9
Background Protection offered by five different forms of immunity, combining natural and vaccine immunity, was investigated against symptomatic SARS-CoV-2 infection from Omicron BA.1 or BA.2, and severe, critical, or fatal COVID-19 from BA.1 or BA.2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cf035bfe8c85b8b268848a7b180ef3c
https://doi.org/10.1093/ofid/ofac492.1591
https://doi.org/10.1093/ofid/ofac492.1591